SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Seiji Shiota, Rita Reddy, Abeer Alsarraj, Hashem B. El-Serag, David Y. Graham, Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans, Clinical Gastroenterology and Hepatology, 2015, 13, 9, 1616

    CrossRef

  2. 2
    Hideo Yonezawa, Takako Osaki, Shigeru Kamiya, Biofilm Formation byHelicobacter pyloriand Its Involvement for Antibiotic Resistance, BioMed Research International, 2015, 2015, 1

    CrossRef

  3. 3
    Hyuk Lee, Sung Noh Hong, Byung-Hoon Min, Jun Haeng Lee, Poong-Lyul Rhee, Yong Chan Lee, Jae J. Kim, Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea, Digestive and Liver Disease, 2015, 47, 2, 114

    CrossRef

  4. 4
    Zhen Lin, Shiliang Cheng, Qin Yan, Xinfeng Liu, Wen Zheng, Xiaomei Hu, Jie Li, Jun Zhang, Tingxiu Xiang, Jian Zheng, Juan Zhang, Development of an Immunochromatographic Lateral Flow Device for Rapid Detection of Helicobacter pylori Stool Antigen, Clinical Biochemistry, 2015,

    CrossRef

  5. 5
    Hyuk Yoon, Nayoung Kim, Diagnosis and Management of High Risk Group for Gastric Cancer, Gut and Liver, 2015, 9, 1, 5

    CrossRef

  6. 6
    Ji Min Choi, Sang Gyun Kim, Diagnosis and Treatment of <i>Helicobacter Pylori</i> Infection: Korean and Overseas Guidelines, The Korean Journal of Medicine, 2015, 89, 2, 157

    CrossRef

  7. 7
    Hale Gokcan, Erkin Oztas, Ibrahim Koral Onal, Different bismuth-based therapies for eradicating Helicobacter pylori: Randomized clinical trial of efficacy and safety, Clinics and Research in Hepatology and Gastroenterology, 2015,

    CrossRef

  8. 8
    Aline Cristina Targa Cadamuro, Ana Flávia Teixeira Rossi, Joice Matos Biselli-Périco, Patrícia Fucuta Pereira, Edla Polsinelli Bedin Mascarin Do Vale, Ricardo Acayaba, Kátia Ramos Moreira Leite, Eny Maria Goloni-Bertollo, Ana Elizabete Silva, Effect ofHelicobacter pyloriEradication on TLR2 and TLR4 Expression in Patients with Gastric Lesions, Mediators of Inflammation, 2015, 2015, 1

    CrossRef

  9. 9
    Efrat Broide, Haim Shirin, Evaluation of Exalenz Bioscience’s BreathID forHelicobacter pyloridetection, Expert Review of Molecular Diagnostics, 2015, 15, 3, 299

    CrossRef

  10. 10
    Toshihiro Nishizawa, Hidekazu Suzuki, Gastric Carcinogenesis and Underlying Molecular Mechanisms:Helicobacter pyloriand Novel Targeted Therapy, BioMed Research International, 2015, 2015, 1

    CrossRef

  11. 11
    Naoki Mori, Hiromasa Fujita, Toshiaki Tanaka, Satoru Matono, Kohei Nishimura, Haruhiro Hino, Kazuo Shirouzu, Susumu Sueyoshi, Gastropericardial fistula in the gastric tube after esophagectomy for cancer, Esophagus, 2015, 12, 3, 272

    CrossRef

  12. 12
    Galit H. Frydman, Nick Davis, Paul L. Beck, James G. Fox, Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography, Helicobacter, 2015, 20, 4
  13. 13
    Masahiro Asaka, Katsuhiro Mabe, Rumiko Matsushima, Momoko Tsuda, Helicobacter pylori Eradication to Eliminate Gastric Cancer, Gastroenterology Clinics of North America, 2015, 44, 3, 639

    CrossRef

  14. 14
    Shota Nakashima, Tomoyuki Kakugawa, Hirokazu Yura, Masaomi Tomonaga, Tatsuhiko Harada, Atsuko Hara, Shintaro Hara, Masayuki Nakano, Eiki Yamasaki, Noriho Sakamoto, Yuji Ishimatsu, Hajime Isomoto, Bernadette R. Gochuico, Anthony F. Suffredini, Hiroshi Mukae, Hisao Kurazono, Toshiya Hirayama, Joel Moss, Shigeru Kohno, Identification of Helicobacter pylori VacA in human lung and its effects on lung cells, Biochemical and Biophysical Research Communications, 2015, 460, 3, 721

    CrossRef

  15. 15
    Michitaka Honda, Naoki Hiki, Souya Nunobe, Manabu Ohashi, Koshi Kumagai, Yoshikazu Hashimoto, Shinji Mine, Satoshi Kamiya, Takeshi Sano, Toshiharu Yamaguchi, Preoperative vs Postoperative Eradication of Helicobacter pylori in 150 Patients with Gastric Cancer: A Randomized Controlled Trial, Journal of the American College of Surgeons, 2015, 221, 2, 273

    CrossRef

  16. 16
    Tomoari Kamada, Motonori Sato, Tadashi Tokutomi, Tetsuo Watanabe, Takahisa Murao, Hiroshi Matsumoto, Noriaki Manabe, Masanori Ito, Shinji Tanaka, Kazuhiko Inoue, Akiko Shiotani, Takashi Akiyama, Jiro Hata, Ken Haruma, Rebamipide Improves Chronic Inflammation in the Lesser Curvature of the Corpus afterHelicobacter pyloriEradication: A Multicenter Study, BioMed Research International, 2015, 2015, 1

    CrossRef

  17. 17
    Yo Han Park, Nayoung Kim, Review of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer, Journal of Cancer Prevention, 2015, 20, 1, 25

    CrossRef

  18. 18
    Ana Candida Araujo e Silva, Fernanda Oliveira Lemos, Marco Túlio Ribeiro Gomes, Carlos Edmundo Salas, Miriam Teresa Paz Lopes, Role of gastric acid inhibition, prostaglandins and endogenous-free thiol groups on the gastroprotective effect of a proteolytic fraction from Vasconcellea cundinamarcensis latex, Journal of Pharmacy and Pharmacology, 2015, 67, 1
  19. 19
    Yong Hwan Kwon, Nayoung Kim, Ju Yup Lee, Yoon Jin Choi, Kichul Yoon, Jae Jin Hwang, Hyun Joo Lee, AeRa Lee, Yeon Sang Jeong, Sooyeon Oh, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, The Diagnostic Validity of Citric Acid-Free, High Dose 13C-Urea Breath Test After Helicobacter pylori Eradication in Korea, Helicobacter, 2015, 20, 3
  20. 20
    Yuichi Sato, Osamu Yoneyama, Masaki Azumaya, Manabu Takeuchi, Syun-ya Sasaki, Junji Yokoyama, Kazuhiko Shioji, Yusuke Kawauchi, Satoru Hashimoto, Yuuki Nishigaki, Masaaki Kobayashi, Kazuhito Sugimura, Terasu Honma, Rintaro Narisawa, Yutaka Aoyagi, The Relationship Between Iron Deficiency in Patients with Helicobacter Pylori-Infected Nodular Gastritis and the Serum Prohepcidin Level, Helicobacter, 2015, 20, 1
  21. 21
    Kichul Yoon, Nayoung Kim, Ryoung H Nam, Ji H Suh, Seonmin Lee, Jung M Kim, Ju Y Lee, Yong H Kwon, Yoon J Choi, Hyuk Yoon, Cheol M Shin, Young S Park, Dong H Lee, Ultimate eradication rate of Helicobacter pylori after first, second, or third-line therapy in Korea, Journal of Gastroenterology and Hepatology, 2015, 30, 3
  22. 22
    Satoshi Sato, Daisuke Chinda, Kiyonori Yamai, Ryu Satake, Yasushi Soma, Tadashi Shimoyama, Shinsaku Fukuda, A case of severe pseudomembranous colitis diagnosed by colonoscopy after Helicobacter pylori eradication, Clinical Journal of Gastroenterology, 2014, 7, 3, 247

    CrossRef

  23. 23
    Tomoyuki Boda, Masanori Ito, Shiro Oka, Yoko Kitamura, Norifumi Numata, Yoji Sanomura, Taiji Matsuo, Shinji Tanaka, Masaharu Yoshihara, Koji Arihiro, Kazuaki Chayama, Characteristics of Metachronous Gastric Tumors after Endoscopic Submucosal Dissection for Gastric Intraepithelial Neoplasms, Gastroenterology Research and Practice, 2014, 2014, 1

    CrossRef

  24. 24
    Toshihiro Nishizawa, Takama Maekawa, Noriko Watanabe, Naohiko Harada, Yasuo Hosoda, Masahiro Yoshinaga, Toshiyuki Yoshio, Hajime Ohta, Syuuji Inoue, Tatsuya Toyokawa, Haruhiro Yamashita, Hiroki Saito, Toshio Kuwai, Shunsuke Katayama, Eiji Masuda, Hideharu Miyabayashi, Toshio Kimura, Yuko Nishizawa, Masahiko Takahashi, Hidekazu Suzuki, Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication, Journal of Clinical Gastroenterology, 2014, 1

    CrossRef

  25. 25
    Hyuk Lee, Hye-Kyung Jung, Kyu Chan Huh, Current status of functional dyspepsia in Korea, The Korean Journal of Internal Medicine, 2014, 29, 2, 156

    CrossRef

  26. You have free access to this content26
    Tadashi Shimoyama, Daisuke Chinda, Masashi Matsuzaka, Ippei Takahashi, Shigeyuki Nakaji, Shinsaku Fukuda, Decrease of serum level of gastrin in healthy Japanese adults by the change of Helicobacter pylori infection, Journal of Gastroenterology and Hepatology, 2014, 29,
  27. 27
    Seung Bae Yoon, Jae Myung Park, Chul-Hyun Lim, Yu Kyung Cho, Myung-Gyu Choi, Effect of Helicobacter pylori Eradication on Metachronous Gastric Cancer after Endoscopic Resection of Gastric Tumors: A Meta-Analysis, Helicobacter, 2014, 19, 4
  28. 28
    Youhua Wang, Ben Wang, Zhi Fa Lv, Yang Yang, Fucai Wang, Hui Wang, Shuping Chen, Yong Xie, Xiaojiang Zhou, Efficacy and Safety of Ecabet Sodium as an Adjuvant Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis, Helicobacter, 2014, 19, 5
  29. 29
    Il Ju Choi, Endoscopic Gastric Cancer Screening and Surveillance in High-Risk Groups, Clinical Endoscopy, 2014, 47, 6, 497

    CrossRef

  30. 30
    M. Okuda, T. Osaki, S. Kikuchi, J. Ueda, Y. Lin, H. Yonezawa, K. Maekawa, F. Hojo, S. Kamiya, Y. Fukuda, Evaluation of a stool antigen test using a mAb for native catalase for diagnosis of Helicobacter pylori infection in children and adults, Journal of Medical Microbiology, 2014, 63, Pt_12, 1621

    CrossRef

  31. 31
    Ju Yup Lee, Nayoung Kim, Min Soo Kim, Yoon Jin Choi, Jung Won Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Hyun Chae Jung, Factors Affecting First-Line Triple Therapy of Helicobacter pylori Including CYP2C19 Genotype and Antibiotic Resistance, Digestive Diseases and Sciences, 2014, 59, 6, 1235

    CrossRef

  32. 32
    Ju Yup Lee, Nayoung Kim, Future Trends ofHelicobacter pyloriEradication Therapy in Korea, The Korean Journal of Gastroenterology, 2014, 63, 3, 158

    CrossRef

  33. 33
    Sang Gyun Kim, Hye-Kyung Jung, Hang Lak Lee, Jae Young Jang, Hyuk Lee, Chan Gyoo Kim, Woon Geon Shin, Ein Soon Shin, Yong Chan Lee, Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition, Journal of Gastroenterology and Hepatology, 2014, 29, 7
  34. 34
    W.- S. Huang, C.- H. Tseng, C.- L. Lin, C.- H. Tsai, C.- H. Kao, Helicobacter pylori infection increases subsequent ischemic stroke risk: a nationwide population-based retrospective cohort study, QJM, 2014, 107, 12, 969

    CrossRef

  35. 35
    Toshihiro Nishizawa, Hidekazu Suzuki, Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing, Frontiers in Molecular Biosciences, 2014, 1,

    CrossRef

  36. 36
    Eun Jeong Gong, Sung-Cheol Yun, Hwoon-Yong Jung, Hyun Lim, Kwi-Sook Choi, Ji Yong Ahn, Jeong Hoon Lee, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Jin-Ho Kim, Meta-Analysis of First-Line Triple Therapy forHelicobacter pyloriEradication in Korea: Is It Time to Change?, Journal of Korean Medical Science, 2014, 29, 5, 704

    CrossRef

  37. 37
    Sun-Young Lee, New Guidelines forHelicobacter pyloriTreatment: Comparisons between Korea and Japan, The Korean Journal of Gastroenterology, 2014, 63, 3, 151

    CrossRef

  38. 38
    K. M. Fock, Review article: the epidemiology and prevention of gastric cancer, Alimentary Pharmacology & Therapeutics, 2014, 40, 3
  39. 39
    Masahiro Asaka, Mototsugu Kato, Naoya Sakamoto, Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan, Journal of Gastroenterology, 2014, 49, 1, 1

    CrossRef

  40. 40
    Sun Hee Park, Jae Young Jang, Seok Ho Dong, Hyo Jong Kim, Byung-Ho Kim, Young Woon Chang, Successful Eradication ofHelicobacter pyloriUsing Modified Quadruple Therapy in Patient with Long-lastingH. pylori-induced Active Gastritis, The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2014, 14, 1, 52

    CrossRef

  41. 41
    Yujin Kobayashi, Yoshihiro Hatta, Yoshihito Uchino, Successful treatment of secondaryHelicobacter pylorieradication for chronic immune thrombocytopenic purpura, Platelets, 2014, 25, 8, 645

    CrossRef

  42. 42
    Young-Il Kim, Il Ju Choi, Myeong-Cherl Kook, Soo-Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Keun Won Ryu, Young-Woo Kim, The Association Between Helicobacter pylori Status and Incidence of Metachronous Gastric Cancer After Endoscopic Resection of Early Gastric Cancer, Helicobacter, 2014, 19, 3
  43. 43
    Jan Bornschein, Marcis Leja, The global challenge of a healthy stomach, Best Practice & Research Clinical Gastroenterology, 2014, 28, 6, 949

    CrossRef

  44. 44
    S. Shiota, M. Cruz, J. A. J. Abreu, T. Mitsui, H. Terao, M. Disla, S. Iwatani, H. Nagashima, M. Matsuda, T. Uchida, L. Tronilo, E. Rodriguez, Y. Yamaoka, Virulence genes of Helicobacter pylori in the Dominican Republic, Journal of Medical Microbiology, 2014, 63, Pt_9, 1189

    CrossRef

  45. 45
    Masahiro Asaka, A new approach for elimination of gastric cancer deaths in Japan, International Journal of Cancer, 2013, 132, 6
  46. 46
    Mototsugu Kato, Shuichi Terao, Kyoichi Adachi, Shigemi Nakajima, Takashi Ando, Norimasa Yoshida, Noriya Uedo, Kazunari Murakami, Shuichi Ohara, Masanori Ito, Naomi Uemura, Takuro Shimbo, Hidenobu Watanabe, Takahiro Kato, Kazunori Ida, Changes in endoscopic findings of gastritis after cure of H. pylori infection: Multicenter prospective trial, Digestive Endoscopy, 2013, 25, 3
  47. 47
    Il Ju Choi, Current evidence of effects ofHelicobacter pylorieradication on prevention of gastric cancer, The Korean Journal of Internal Medicine, 2013, 28, 5, 525

    CrossRef

  48. 48
    Sung Eun Kim, Young Soo Park, Nayoung Kim, Min Soo Kim, Hyun Jin Jo, Cheol Min Shin, Sang Hyub Lee, Jin-Hyeok Hwang, Jin-Wook Kim, Sook-Hyang Jeong, Dong Ho Lee, Hyun Chae Jung, Effect of Eradication on Functional Dyspepsia, Journal of Neurogastroenterology and Motility, 2013, 19, 2, 233

    CrossRef

  49. 49
    Sreenivasulu Puram, Hyung Chae Suh, Seung Un Kim, Bharathi Bethapudi, Joshua Allan Joseph, Amit Agarwal, Venkateswarlu Kudiganti, Effect of GutGard in the Management ofHelicobacter pylori: A Randomized Double Blind Placebo Controlled Study, Evidence-Based Complementary and Alternative Medicine, 2013, 2013, 1

    CrossRef

  50. 50
    Ravi N. Sharaf, Amandeep K. Shergill, Robert D. Odze, Mary L. Krinsky, Norio Fukami, Rajeev Jain, Vasundhara Appalaneni, Michelle A. Anderson, Tamir Ben-Menachem, Vinay Chandrasekhara, Krishnavel Chathadi, G. Anton Decker, Dana Early, John A. Evans, Robert D. Fanelli, Deborah A. Fisher, Laurel R. Fisher, Kimberly Q. Foley, Joo Ha Hwang, Terry L. Jue, Steven O. Ikenberry, Khalid M. Khan, Jennifer Lightdale, Phyllis M. Malpas, John T. Maple, Shabana Pasha, John Saltzman, Jason A. Dominitz, Brooks D. Cash, Endoscopic mucosal tissue sampling, Gastrointestinal Endoscopy, 2013, 78, 2, 216

    CrossRef

  51. 51
    H. J. Lee, J. I. Kim, D. Y. Cheung, T. H. Kim, E. J. Jun, J.-H. Oh, W. C. Chung, B.-W. Kim, S. S. Kim, S.-H. Park, J. K. Kim, Eradication of Helicobacter pylori According to 23S Ribosomal RNA Point Mutations Associated With Clarithromycin Resistance, Journal of Infectious Diseases, 2013, 208, 7, 1123

    CrossRef

  52. 52
    Sang Gyun Kim, Hye-Kyung Jung, Hang Lak Lee, Jae Young Jang, Hyuk Lee, Chan Gyoo Kim, Woon Geon Shin, Ein Soon Shin, Yong Chan Lee, Guidelines for the Diagnosis and Treatment ofHelicobacter pyloriInfection in Korea, 2013 Revised Edition, The Korean Journal of Gastroenterology, 2013, 62, 1, 3

    CrossRef

  53. 53
    Peter Malfertheiner, Marino Venerito, Michael Selgrad, Helicobacter pylori infection, Current Opinion in Gastroenterology, 2013, 29, 6, 669

    CrossRef

  54. 54
    Hidekazu Suzuki, Paul Moayyedi, Helicobacter pylori infection in functional dyspepsia, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 3, 168

    CrossRef

  55. 55
    Chan Gyoo Kim, Helicobacter pyloriand Hematologic Diseases, Korean Journal of Medicine, 2013, 84, 6, 769

    CrossRef

  56. 56
    Sang Yong Kim, Bin Cho, Helicobacter pyloriInfection and Hematologic Diseases, The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2013, 13, 4, 214

    CrossRef

  57. 57
    Seiji Shiota, Kazunari Murakawi, Rumiko Suzuki, Toshio Fujioka, Yoshio Yamaoka, Helicobacter pyloriinfection in Japan, Expert Review of Gastroenterology & Hepatology, 2013, 7, 1, 35

    CrossRef

  58. 58
    Sooyeon Lee, Jong-Min Park, Sang-Ho Park, Eun-Hee Kim, Ki Baik Hahm, The Korean Perspective of Helicobacter pylori Infection: Lessons from Japan Policy to Prevent Gastric Cancer, Journal of Cancer Prevention, 2013, 18, 2, 107

    CrossRef

  59. 59
    Toshio Fujioka, Nobuo Aoyama, Kyoko Sakai, Yoshiyuki Miwa, Mineo Kudo, Junichi Kawashima, Yasuo Matsubara, Jun Miwa, Koji Yakabi, A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan, Journal of Gastroenterology, 2012, 47, 3, 276

    CrossRef

  60. 60
    Olga Silva, Sílvia Viegas, Cristina de Mello-Sampayo, Maria João P. Costa, Rita Serrano, José Cabrita, Elsa T. Gomes, Anti-Helicobacter pylori activity of Terminalia macroptera root, Fitoterapia, 2012, 83, 5, 872

    CrossRef

  61. 61
    Seiji Shiota, Lam Tung Nguyen, Kazunari Murakami, Akiko Kuroda, Kazuhiro Mizukami, Tadayoshi Okimoto, Masaaki Kodama, Toshio Fujioka, Yoshio Yamaoka, Association of Helicobacter pylori dupA With the Failure of Primary Eradication, Journal of Clinical Gastroenterology, 2012, 46, 4, 297

    CrossRef

  62. You have free access to this content62
    Masami Sato, Tadashi Shimoyama, Ryoki Takahashi, Hirofumi Kajiyama, Yukari Sano, Naomi Sakaedani, Azusa Kato, Haruhisa Hirata, Yoshihiro Fukuda, Characterization and usefulness of stool antigen tests using a monoclonal antibody to Helicobacter pylori catalase, Journal of Gastroenterology and Hepatology, 2012, 27,
  63. 63
    Joong Ho Lee, Kyung Min Kim, Jae-Ho Cheong, Sung Hoon Noh, Current Management and Future Strategies of Gastric Cancer, Yonsei Medical Journal, 2012, 53, 2, 248

    CrossRef

  64. You have free access to this content64
    Masumi Okuda, Noriyasu Yamamoto, Nobuhisa Fukuda, Kohei Maekawa, Takeshi Kusaka, Manabu Hashimoto, Junichiro Kotake, Hiromasa Koizuka, Yoshihiro Fukuda, Effect of ecabet sodium treatment on urea breath test and stool antigen tests in volunteers with Helicobacter pylori infection, Journal of Gastroenterology and Hepatology, 2012, 27,
  65. 65
    Emiko Rimbara, Norihisa Noguchi, Takashi Kawai, Masanori Sasatsu, Fluoroquinolone Resistance in Helicobacter pylori: Role of Mutations at Position 87 and 91 of GyrA on the Level of Resistance and Identification of a Resistance Conferring Mutation in GyrB, Helicobacter, 2012, 17, 1
  66. 66
    Shouko Ono, Mototsugu Kato, Mio Suzuki, Saori Ishigaki, Masakazu Takahashi, Masahira Haneda, Katsuhiro Mabe, Yuichi Shimizu, Frequency of Helicobacter pylori-Negative Gastric Cancer and Gastric Mucosal Atrophy in a Japanese Endoscopic Submucosal Dissection Series Including Histological, Endoscopic and Serological Atrophy, Digestion, 2012, 86, 1, 59

    CrossRef

  67. 67
    M. Gasparetto, M. Pescarin, G. Guariso, Helicobacter pylori Eradication Therapy: Current Availabilities, ISRN Gastroenterology, 2012, 2012, 1

    CrossRef

  68. 68
    Jie Liang, Jun Li, Ying Han, Jielai Xia, Yunsheng Yang, Wen Li, Shutian Zhang, Yongdong Wu, Yaozong Yuan, Zhaoshen Li, Yiqi Du, Minhu Chen, Baili Chen, Bo Jiang, Yang Bai, Qinsheng Wen, Kaichun Wu, Daiming Fan, Helicobacter pylori Eradication with Ecabet Sodium, Omeprazole, Amoxicillin, and Clarithromycin Versus Bismuth, Omeprazole, Amoxicillin, and Clarithromycin Quadruple Therapy: A Randomized, Open-Label, Phase IV Trial, Helicobacter, 2012, 17, 6
  69. 69
    En-ling Leung Ki, Francis K.L. Chan, Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: Implications for clinical practice, Best Practice & Research Clinical Gastroenterology, 2012, 26, 2, 163

    CrossRef

  70. 70
    Kentaro Sugano, Teiji Kontani, Shinichi Katsuo, Yoshinori Takei, Nobuhiro Sakaki, Kiyoshi Ashida, Yuji Mizokami, Masahiro Asaka, Shigeyuki Matsui, Tatsuya Kanto, Satoshi Soen, Tsutomu Takeuchi, Hideyuki Hiraishi, Naoki Hiramatsu, Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial, Journal of Gastroenterology, 2012, 47, 5, 540

    CrossRef

  71. 71
    Yuji Maehata, Shotaro Nakamura, Kiyoshi Fujisawa, Motohiro Esaki, Tomohiko Moriyama, Kouichi Asano, Yuta Fuyuno, Kan Yamaguchi, Issei Egashira, Hyonji Kim, Motonobu Kanda, Minako Hirahashi, Takayuki Matsumoto, Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer, Gastrointestinal Endoscopy, 2012, 75, 1, 39

    CrossRef

  72. You have free access to this content72
    Shigemi Nakajima, Hisayuki Inoue, Tetsuya Inoue, Yuri Maruoka, Multiple-antibiotic-resistant Helicobacter pylori infection eradicated with a tailor-made quadruple therapy, Journal of Gastroenterology and Hepatology, 2012, 27,
  73. 73
    Takeshi Matsuhisa, Hafeza Aftab, Observation of Gastric Mucosa in Bangladesh, the Country with the Lowest Incidence of Gastric Cancer, and Japan, the Country with the Highest Incidence, Helicobacter, 2012, 17, 5
  74. 74
    Toshihiro Nishizawa, Hidekazu Suzuki, Masayuki Suzuki, Masahiko Takahashi, Toshifumi Hibi, Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy, Journal of Clinical Biochemistry and Nutrition, 2012, 51, 2, 114

    CrossRef

  75. 75
    M. Kato, M. Asaka, Recent Development of Gastric Cancer Prevention, Japanese Journal of Clinical Oncology, 2012, 42, 11, 987

    CrossRef

  76. 76
    Hirokazu ISOBE, Akihito NISHIYAMA, Tomomi TAKANO, Wataru HIGUCHI, Saori NAKAGAWA, Ikue TANEIKE, Yoichi FUKUSHIMA, Tatsuo YAMAMOTO, Reduction of OverallHelicobacter pyloriColonization Levels in the Stomach of Mongolian Gerbil byLactobacillus johnsoniiLa1 (LC1) and Itsin VitroActivities againstH. pyloriMotility and Adherence, Bioscience, Biotechnology and Biochemistry, 2012, 76, 4, 850

    CrossRef

  77. 77
    Soichiro Miura, Ryota Hokari, Seeking an optimal eradication therapy for Helicobacter pylori infection, Journal of Gastroenterology and Hepatology, 2012, 27, 1
  78. 78
    Masanori Ito, Masaharu Yoshihara, Shunsuke Takata, Yoshihiro Wada, Taiji Matsuo, Tomoyuki Boda, Shinji Tanaka, Kazuaki Chayama, Serum screening for detection of high-risk group for early-stage diffuse type gastric cancer in Japanese, Journal of Gastroenterology and Hepatology, 2012, 27, 3
  79. 79
    Yoshihiro Hirata, Tomoya Ohmae, Ayako Yanai, Kosuke Sakitani, Yoku Hayakawa, Shuntaro Yoshida, Takafumi Sugimoto, Yuzo Mitsuno, Masao Akanuma, Yutaka Yamaji, Keiji Ogura, Shin Maeda, Kazuhiko Koike, Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan, International Journal of Antimicrobial Agents, 2012, 39, 4, 352

    CrossRef

  80. 80
    Ji Hyuk Kang, Yun Jeong Lim, Trend for Treatment ofHelicobacter pyloriin Overseas Country, The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2012, 12, 4, 224

    CrossRef

  81. You have free access to this content81
    Ivan Reva, Tomomi Takano, Wataru Higuchi, Yasuhisa Iwao, Ikue Taneike, Saori Nakagawa, Masami Ike, Oleg Pererva, Alexey Tarankov, Mikhail Agapov, Evgeniy Rizhkov, Olga Singur, Galina Reva, Vladimir Potapov, Tatsuo Yamamoto, Virulence genotypes and drug resistance of Helicobacter pylori from Vladivostok, Russia: another feature in the Far East, Microbiology and Immunology, 2012, 56, 3
  82. 82
    Tadashi Shimoyama, Manabu Sawaya, Atsushi Ishiguro, Norihiro Hanabata, Tetsuro Yoshimura, Shinsaku Fukuda, Applicability of a rapid stool antigen test, using monoclonal antibody to catalase, for the management of Helicobacter pylori infection, Journal of Gastroenterology, 2011, 46, 4, 487

    CrossRef

  83. 83
    Soichiro Miura, Kentaro Sugano, Yoshikazu Kinoshita, Kwong Ming Fock, Khean Lee Goh, Peter Gibson, Diagnosis and treatment of functional gastrointestinal disorders in the Asia-Pacific region: A survey of current practices, Journal of Gastroenterology and Hepatology, 2011, 26,
  84. 84
    Kazutoshi Hori, Hiroto Miwa, Takayuki Matsumoto, Efficacy of 2-Week, Second-Line Helicobacter pylori Eradication Therapy Using Rabeprazole, Amoxicillin, and Metronidazole for the Japanese Population, Helicobacter, 2011, 16, 3
  85. You have free access to this content85
    Khean-Lee Goh, Wah-Kheong Chan, Seiji Shiota, Yoshio Yamaoka, Epidemiology of Helicobacter pylori Infection and Public Health Implications, Helicobacter, 2011, 16,
  86. 86
    Peter Malfertheiner, Gastric Atrophy Reversible or Irreversible after <i>Helicobacter pylori</i> Eradication – An Open Question, Digestion, 2011, 83, 4, 250

    CrossRef

  87. 87
    Kazumasa MIKI, Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method”, Proceedings of the Japan Academy, Series B, 2011, 87, 7, 405

    CrossRef

  88. 88
    Jan Bornschein, Peter Malfertheiner, Gastric carcinogenesis, Langenbeck's Archives of Surgery, 2011, 396, 6, 729

    CrossRef

  89. 89
    Michael Selgrad, Jan Bornschein, Peter Malfertheiner, Guidelines for treatment ofHelicobacter pyloriin the East and West, Expert Review of Anti-infective Therapy, 2011, 9, 8, 581

    CrossRef

  90. 90
    Peter Malfertheiner, Franco Bazzoli, Jean-Charles Delchier, Krysztof Celiñski, Monique Giguère, Marc Rivière, Francis Mégraud, Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial, The Lancet, 2011, 377, 9769, 905

    CrossRef

  91. 91
    Seung Young Kim, Sung Woo Jung, Helicobacter pyloriEradication Therapy in Korea, The Korean Journal of Gastroenterology, 2011, 58, 2, 67

    CrossRef

  92. 92
    T. Takano, W. Higuchi, H. Kanda, T. Yamamoto, In vitro activity of DX-619, a des-F(6)-quinolone, against Helicobacter pylori, Journal of Antimicrobial Chemotherapy, 2011, 66, 1, 220

    CrossRef

  93. 93
    Kentaro Sugano, Yasushi Matsumoto, Tsukasa Itabashi, Sumihisa Abe, Nobuhiro Sakaki, Kiyoshi Ashida, Yuji Mizokami, Tsutomu Chiba, Shigeyuki Matsui, Tatsuya Kanto, Kazuyuki Shimada, Shinichiro Uchiyama, Naomi Uemura, Naoki Hiramatsu, Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial, Journal of Gastroenterology, 2011, 46, 6, 724

    CrossRef

  94. 94
    Hidekazu Suzuki, Juntaro Matsuzaki, Toshifumi Hibi, Metronidazole-based quadruple versus standard triple therapy: which is better as first-line therapy forHelicobacter pylorieradication?, Expert Review of Clinical Pharmacology, 2011, 4, 5, 579

    CrossRef

  95. 95
    Soo Hee Chang, Organic Upper Digestive Diseases in Children with Chronic Abdominal Pain, Korean Journal of Pediatric Gastroenterology and Nutrition, 2011, 14, 3, 232

    CrossRef

  96. 96
    Seiko Kubota, Kazuyoshi Yamauchi, Mitsutoshi Sugano, Kenji Kawasaki, Atsushi Sugiyama, Kenji Matsuzawa, Taiji Akamatsu, Yasukazu Ohmoto, Hiroyoshi Ota, Pathophysiological Investigation of the Gastric Surface Mucous Gel Layer of Patients with Helicobacter pylori Infection by Using Immunoassays for Trefoil Factor Family 2 and Gastric Gland Mucous Cell-Type Mucin in Gastric Juice, Digestive Diseases and Sciences, 2011, 56, 12, 3498

    CrossRef

  97. 97
    Norihiro Furusyo, Ahmed H. Walaa, Kunimitsu Eiraku, Kazuhiro Toyoda, Eiichi Ogawa, Hiroaki Ikezaki, Takeshi Ihara, Takeo Hayashi, Mosaburo Kainuma, Masayuki Murata, Jun Hayashi, Treatment for Eradication of Helicobacter pylori Infection among Chronic Hepatitis C Patients, Gut and Liver, 2011, 5, 4, 447

    CrossRef

  98. 98
    Amin Talebi Bezmin Abadi, Ashraf M. Mobarez, Tarang Taghvaei, Lutz Wolfram, Antibiotic Resistance of Helicobacter pylori in Mazandaran, North of Iran, Helicobacter, 2010, 15, 6
  99. 99
    Tadashi Shimoyama, Intetsu Kobayashi, Chieko Kato, Masaaki Kodama, Yoshihiro Fukuda, Comparison of monoclonal antibody-based stool antigen tests to determine the results ofHelicobacter pylorieradication therapy, Scandinavian Journal of Gastroenterology, 2010, 45, 12, 1431

    CrossRef

  100. You have free access to this content100
    Xavier Calvet, Philippe Lehours, Sergio Lario, Francis Mégraud, Diagnosis of Helicobacter pylori Infection, Helicobacter, 2010, 15,
  101. 101
    Peter Malfertheiner, Michael Selgrad, Helicobacter pylori infection and current clinical areas of contention, Current Opinion in Gastroenterology, 2010, 26, 6, 618

    CrossRef

  102. 102
    Masahiro Asaka, Mototsugu Kato, David Y. Graham, Prevention of Gastric Cancer by Helicobacter pylori Eradication, Internal Medicine, 2010, 49, 7, 633

    CrossRef

  103. 103
    M. Kato, M. Asaka, Recent Knowledge of the Relationship Between Helicobacter pylori and Gastric Cancer and Recent Progress of Gastroendoscopic Diagnosis and Treatment for Gastric Cancer, Japanese Journal of Clinical Oncology, 2010, 40, 9, 828

    CrossRef

  104. 104
    Seiji Shiota, Osamu Matsunari, Masahide Watada, Yoshio Yamaoka, SerumHelicobacter pyloriCagA antibody as a biomarker for gastric cancer in east-Asian countries, Future Microbiology, 2010, 5, 12, 1885

    CrossRef

  105. 105
    Masahiro Asaka, Mototsugu Kato, David Y. Graham, Strategy for Eliminating Gastric Cancer in Japan, Helicobacter, 2010, 15, 6
  106. 106
    Yuhong Yuan, Alex C Ford, Khurram J Khan, Javier P Gisbert, David Forman, Grigorios I Leontiadis, Frances Tse, Xavier Calvet, Carlo Fallone, Lori Fischbach, Giuseppina Oderda, Franco Bazzoli, Paul Moayyedi, Optimum duration of regimens for Helicobacter pylori eradication, The Cochrane Library,
  107. 107
    Anthony O'Connor, Deirdre McNamara, Colm A O'Moráin, Surveillance of gastric intestinal metaplasia for the prevention of gastric cancer, The Cochrane Library,